» Articles » PMID: 36329470

Exploring Risk Factors for Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: Construction of a Novel Population-based Predictive Model

Overview
Publisher Biomed Central
Specialty Endocrinology
Date 2022 Nov 4
PMID 36329470
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Machine learning was a highly effective tool in model construction. We aim to establish a machine learning-based predictive model for predicting the cervical lymph node metastasis (LNM) in papillary thyroid microcarcinoma (PTMC).

Methods: We obtained data on PTMC from the SEER database, including 10 demographic and clinicopathological characteristics. Univariate and multivariate logistic regression (LR) analyses were applied to screen the risk factors for cervical LNM in PTMC. Risk factors with P < 0.05 in multivariate LR analysis were used as modeling variables. Five different machine learning (ML) algorithms including extreme gradient boosting (XGBoost), random forest (RF), adaptive boosting (AdaBoost), gaussian naive bayes (GNB) and multi-layer perceptron (MLP) and traditional regression analysis were used to construct the prediction model. Finally, the area under the receiver operating characteristic (AUROC) curve was used to compare the model performance.

Results: Through univariate and multivariate LR analysis, we screened out 9 independent risk factors most closely associated with cervical LNM in PTMC, including age, sex, race, marital status, region, histology, tumor size, and extrathyroidal extension (ETE) and multifocality. We used these risk factors to build an ML prediction model, in which the AUROC value of the XGBoost algorithm was higher than the other 4 ML algorithms and was the best ML model. We optimized the XGBoost algorithm through 10-fold cross-validation, and its best performance on the training set (AUROC: 0.809, 95%CI 0.800-0.818) was better than traditional LR analysis (AUROC: 0.780, 95%CI 0.772-0.787).

Conclusions: ML algorithms have good predictive performance, especially the XGBoost algorithm. With the continuous development of artificial intelligence, ML algorithms have broad prospects in clinical prognosis prediction.

Citing Articles

Deep learning prediction model for central lymph node metastasis in papillary thyroid microcarcinoma based on cytology.

Ren W, Zhu Y, Wang Q, Song Y, Fan Z, Bai Y Cancer Sci. 2023; 114(10):4114-4124.

PMID: 37574759 PMC: 10551586. DOI: 10.1111/cas.15930.


A molecular classification of gastric cancer associated with distinct clinical outcomes and validated by an XGBoost-based prediction model.

Li B, Zhang F, Niu Q, Liu J, Yu Y, Wang P Mol Ther Nucleic Acids. 2023; 31:224-240.

PMID: 36700042 PMC: 9843270. DOI: 10.1016/j.omtn.2022.12.014.

References
1.
Dirikoc A, Tam A, Ince N, Ozdemir D, Topaloglu O, Alkan A . Papillary thyroid microcarcinomas that metastasize to lymph nodes. Am J Otolaryngol. 2021; 42(5):103023. DOI: 10.1016/j.amjoto.2021.103023. View

2.
Limberg J, Ullmann T, Stefanova D, Buicko J, Finnerty B, Zarnegar R . Does Aggressive Variant Histology Without Invasive Features Predict Overall Survival in Papillary Thyroid Cancer?: A National Cancer Database Analysis. Ann Surg. 2019; 274(3):e276-e281. DOI: 10.1097/SLA.0000000000003632. View

3.
Xie W, Ji M, Zhao M, Lam K, Chow C, Hao T . Developing Machine Learning and Statistical Tools to Evaluate the Accessibility of Public Health Advice on Infectious Diseases among Vulnerable People. Comput Intell Neurosci. 2021; 2021:1916690. PMC: 8683224. DOI: 10.1155/2021/1916690. View

4.
Lin D, Qu N, Shi R, Lu Z, Ji Q, Wu W . Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma. Onco Targets Ther. 2016; 9:5307-16. PMC: 5004998. DOI: 10.2147/OTT.S107913. View

5.
Vaccarella S, Dal Maso L, Laversanne M, Bray F, Plummer M, Franceschi S . The Impact of Diagnostic Changes on the Rise in Thyroid Cancer Incidence: A Population-Based Study in Selected High-Resource Countries. Thyroid. 2015; 25(10):1127-36. DOI: 10.1089/thy.2015.0116. View